Macfarlane Group (MACF)

Sector:

Support

Index:

FTSE Small Cap

114.50p
   
  • Change Today:
    -0.50p
  • 52 Week High: 130.50
  • 52 Week Low: 95.40
  • Currency: UK Pounds
  • Shares Issued: 159.60m
  • Volume: 808
  • Market Cap: £182.74m
  • RiskGrade: 179
  • Beta: 0.02

Macfarlane buys foam packaging firm Polyformes for £11.5m

By Benjamin Chiou

Date: Monday 08 Jul 2024

LONDON (ShareCast) - (Sharecast News) - Scottish packaging firm Macfarlane Group announced on Monday it is spending £11.5m to buy foam specialist Polyformes.
The deal, which includes an earn-out of up to £4.8m based on profit targets over two years, is part of Macfarlane's "buy-and-build" strategy.

"This earnings-enhancing acquisition demonstrates further progress in our strategy to build the group's protective packaging business through a combination of organic and acquisitive growth," the company said in a statement.

Founded in 1977, Polyformes makes foam protective packaging for UK customers in the aerospace, medical, defence and industrial sectors.

Macfarlane will take on its 60 employees, including management, and expects both sides to benefit from respectiev industry expertise and common supplier base.

The deal is will be financed from existing bank facilities.

"Polyformes is a profitable, growing, well invested company with an experienced management team that is fully committed to the business," said chief executive Peter Atkinson.

"We look forward to working with the team at Polyformes to support its continued growth and develop opportunities for us to work together to provide our customers with a broader portfolio of protective packaging solutions."

Macfarlane's shares were up 1.7% at 119p by 0952 BST.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

MACF Market Data

Currency UK Pounds
Share Price 114.50p
Change Today -0.50p
% Change -0.43 %
52 Week High 130.50
52 Week Low 95.40
Volume 808
Shares Issued 159.60m
Market Cap £182.74m
Beta 0.02
RiskGrade 179

MACF Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
7.89% below the market average7.89% below the market average7.89% below the market average7.89% below the market average7.89% below the market average
13.33% above the sector average13.33% above the sector average13.33% above the sector average13.33% above the sector average13.33% above the sector average
Price Trend
34.63% above the market average34.63% above the market average34.63% above the market average34.63% above the market average34.63% above the market average
44.33% above the sector average44.33% above the sector average44.33% above the sector average44.33% above the sector average44.33% above the sector average
Income
21.75% above the market average21.75% above the market average21.75% above the market average21.75% above the market average21.75% above the market average
8.47% above the sector average8.47% above the sector average8.47% above the sector average8.47% above the sector average8.47% above the sector average
Growth
56.58% below the market average56.58% below the market average56.58% below the market average56.58% below the market average56.58% below the market average
56.52% below the sector average56.52% below the sector average56.52% below the sector average56.52% below the sector average56.52% below the sector average

What The Brokers Say

Strong Buy 1
Buy 1
Neutral 0
Sell 0
Strong Sell 0
Total 2
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

MACF Dividends

  Latest Previous
  Final Interim
Ex-Div 15-May-25 12-Sep-24
Paid 13-Jun-25 10-Oct-24
Amount 2.70p 0.96p

Trades for 30-May-2025

Time Volume / Share Price
08:45 51 @ 115.47p
08:36 3 @ 115.50p
08:09 738 @ 114.73p
08:00 16 @ 114.50p
08:00 12 @ 114.50p

MACF Key Personnel

CEO Peter Atkinson
Chair Aleen Gulvanessian

Top of Page